Johnson & Johnson to Acquire Cardiovascular Treatment Company V-Wave For $600M Upfront With Earnout Up To $1.1B, To Dilute Adj EPS By $0.24 in FY24 And $0.06 By FY25
Portfolio Pulse from Benzinga Newsdesk
Johnson & Johnson (NYSE:JNJ) is set to acquire V-Wave Ltd., a company specializing in heart failure treatments, for $600 million upfront, with potential additional payments up to $1.1 billion. V-Wave will become part of Johnson & Johnson MedTech.
August 20, 2024 | 11:32 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Johnson & Johnson is acquiring V-Wave Ltd. for $600 million upfront, with potential additional payments up to $1.1 billion. This acquisition will enhance J&J's MedTech division with innovative heart failure treatments.
The acquisition of V-Wave Ltd. by Johnson & Johnson is a strategic move to enhance its MedTech division with innovative cardiovascular treatments. The upfront payment of $600 million and potential earnouts indicate a significant investment, likely to positively impact J&J's market position in the healthcare sector.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100